Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16734623rdf:typepubmed:Citationlld:pubmed
pubmed-article:16734623lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0026764lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C1171362lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C1515670lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C2709199lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C1511636lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:16734623lifeskim:mentionsumls-concept:C0205296lld:lifeskim
pubmed-article:16734623pubmed:issue3lld:pubmed
pubmed-article:16734623pubmed:dateCreated2006-5-31lld:pubmed
pubmed-article:16734623pubmed:abstractTextgammadelta T cells account for up to 10% of T lymphocytes in the peripheral blood of healthy donors. They can be activated by cytokines such as interleukin (IL)-2, IL-12 and IL-15, express natural killer (NK) cell markers such as NKG2D and show cytotoxic activity against several tumour cells, including multiple myeloma. Here, we present activated polyclonal gammadelta T cells from healthy donors with an NK T cell-like phenotype expressing the natural cytotoxicity receptor NKp44. Natural cytotoxicity receptors NKp30, NKp44 and NKp46 have been regarded as specific NK receptors; only two gammadelta T cell clones described so far expressed NKp 44. Isolated polyclonal gammadelta T cells cultured for 7 days according to the cytokine-induced killer cell (CIK) protocol with additional IL-15 revealed a surface expression of NKp44 of 8+/-7% (n=22). This could be confirmed by detection of NKp 44 mRNA by reverse transcription-polymerase chain reaction (RT-PCR). gammadelta T cells exhibited a marked cytotoxic activity against myeloma cells, which could be reduced by inhibition of NKp44. To our knowledge, this is the first description of the expression of NKp44 on polyclonal gammadelta T cells.lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:languageenglld:pubmed
pubmed-article:16734623pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:citationSubsetIMlld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16734623pubmed:statusMEDLINElld:pubmed
pubmed-article:16734623pubmed:monthJunlld:pubmed
pubmed-article:16734623pubmed:issn0009-9104lld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:FeldmannGGlld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:FrankSSlld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:SieversEElld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:StrehlJJlld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:NattermannJJlld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:von...lld:pubmed
pubmed-article:16734623pubmed:authorpubmed-author:Schmidt-WolfI...lld:pubmed
pubmed-article:16734623pubmed:issnTypePrintlld:pubmed
pubmed-article:16734623pubmed:volume144lld:pubmed
pubmed-article:16734623pubmed:ownerNLMlld:pubmed
pubmed-article:16734623pubmed:authorsCompleteYlld:pubmed
pubmed-article:16734623pubmed:pagination528-33lld:pubmed
pubmed-article:16734623pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:meshHeadingpubmed-meshheading:16734623...lld:pubmed
pubmed-article:16734623pubmed:year2006lld:pubmed
pubmed-article:16734623pubmed:articleTitleActivated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.lld:pubmed
pubmed-article:16734623pubmed:affiliationMedizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Sigmund Freud Str. 25, 53105 Bonn, Germany. m.lilienfeld.toal@uni-bonn.delld:pubmed
pubmed-article:16734623pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16734623pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16734623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16734623lld:pubmed